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Tissue engineering knowledge is a step toward the treatment of irreversible damages to human 
beings. In the present study, PCL/Gel, PCL/Gel/nHA, PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit D3 
(Polycaprolactone/Gelatin/Nanohydroxyapatite/Vitamin D3) composite scaffolds were 
successfully constructed using electrospinning method. The proliferation and differentiation of 
hADSCs into the bone phenotype were determined using MTT method, ALP activity, Von Kossa 
and Alizarin red staining, and qRT-PCR test. The simultaneous presence of nHA and vitamin D3 
led to the increased activity of ALP in the early stages (on the 14th day) and increased 
mineralization in the late stages (on the 21th day) in differentiated hADSCs. Further, it was found 
that the use of nHA and vitamin D3 resulted in increased expression of BGLAP and COLL I and 
reduced expression of ALP and RUNX2 in hADSCs for 21 days. The results indicated that nHA 
and vitamin D3 have a synergistic effect on the osteogenic differentiation of hADSCs. 
Keywords: Bone Tissue Engineering; HA nanoparticles; Vitamin D3; Human Adipose-Derived 
Mesenchymal Stem Cells; Osteogenic Differentiation.
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1. INTRODUCTION
Craniofacial lesions occur due to trauma, periodontal disease, congenital and acquired defects, 
and bone respective surgery leads to decreased bone volume. This defect could not be restored 
naturally and requires an alternative bone graft. Autogenous bone graft is still considered as the 
gold standard for repairing such bone lesions. However, disadvantages of this method such as 
being limited as well as having painful surgery process and risk of infection, bleeding, nerve 
damage and loss of function have led researchers to seek an alternative method [1]. Tissue 
engineering, known as the knowledge of designing and constructing new tissue, emerged in the 
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early 90s in order to restore the function of defective organs or lost tissues. Principles of tissue 
engineering, cellular and molecular biologic expansion, and tissue formation are based on 
biological engineering. Perception of the function of cells and structure of the extracellular 
matrix, as well as sufficient knowledge about the construction of scaffolds to create an 
environment suitable for adhesion and maintenance of cells, are key concepts in tissue 
engineering. Bone tissue engineering necessarily requires three components: bone precursor cells, 
bone growth factor and a scaffold for adhesion and maintenance of cellular function [2].
New developments in the production of scaffolds as tissue substitutes are directed towards 
modeling of a natural extracellular matrix of tissues or substituted members. Production of 
scaffolds from nanofibers with natural extracellular matrix properties is more beneficial. At the 
start of the new century, many researchers have used electrospinning technique to produce 
nanofiber scaffolds. Electrospinning seems to be the only technique to manufacture continuous 
nanofibers at high rates. Thus, today, electrospinning process is widely used to produce 
nanofibers [3].
There are various natural and artificial polymers used in bone tissue engineering. Among them, 
polycaprolactone has many medical applications and is more suitable due to its compatibility 
with most drugs, cost-effective price and solubility in most organic solvents [4]. Yoshimoto et al., 
fabricated PCL fibrous scaffold using electrospinning technique and cultured rat mesenchymal 
stem cells (MSCs) on the scaffold [5]. The SEM images showed that the polymer-cell structure 
surface was covered with four layers of cells within four weeks. In addition, the mineral structure 
and collagen type 1 were observed during four weeks. They suggested that the electrospun PCL 
is a suitable candidate for bone tissue engineering applications [5]. But, the lack of bioactivity on 
these polymers is a problem due to lack cellular recognition sites [4].
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Gelatin is a natural polymer derived from collagen throughout the hydrolysis process, which has 
a composition similar to that of collagen that is the main compound of ECM [6]. Gelatin has 
highly good adhesion, proliferation, and cellular differentiation properties; however, its low 
mechanical strength and high degradation rates have limited the use of this polymer in tissue 
engineering applications. Gelatin can improve PCL biodegradability for many bio applications 
and reduces the high cost of ultimate products. Therefore, with the proper combination of 
polycaprolactone and gelatin, one can overcome the critical constraints of both and improves the 
mechanical properties and degradation of the composition so that this compound becomes 
suitable for many biomedical applications [7].
In recent years, a number of researchers has emphasized the benefits of using nanocomposites in 
bone graft. The better performance of nanocomposites compared to integrated and conventional 
composites can be attributed to their similarity to the normal bone, which itself is a 
nanocomposite containing mainly HA nanocrystals and collagen nanofibers. Lary Hench., 
introduced polymer/apatite composite as the third generation of biomaterials, in which apatite 
crystals as nanorod (the apatite crystals contained in the bone are as elongated and directed 
particles) are parallel to the direction of the polymer fibers (preferably collagen) [8]. Wutti 
charoenmongkol et al., produced a new bone scaffold from a PCL solution containing 
hydroxyapatite nanoparticles using electrospinning method. They observed that the fiber diameter 
was increased by enhancing nanoparticle percentage or polymer solution concentration. Toxicity 
testing by osteoblasts has shown that these fibers are non-toxic and an appropriate candidate for 
bone repair applications. The presence of nanoparticles in PCL fibers increased the strength from 
2.8 MPa to 3.6 - 3.9 MPa. They stated that increased fiber diameter due to the elevated 
percentage of nanoparticles is probably responsible for enhancing the observed strength [9]. In a 
5
research, Yu et al., applied PCL/HA fibrous scaffold for bone reconstruction [10]. The use of HA 
increased the fiber wettability. Experiments showed that the increased adhesion of rat-derived 
osteoblasts on PCL/HA scaffold. The SEM images of the fibers immersed in simulated body 
fluid showed that the surface of the fibers was coated entirely with HA crystals after 7 days [10]. 
Research on nanostructured and nanoceramic biocomposites suggests that these materials are a 
good choice for bone tissue engineering applications and have improved biocompatibility and 
mechanical properties. The combination of polymer fibers and bioactive nanoparticles can be 
used to produce composite nanofibers [11]. Scaffold bioactivity stimulates cells towards 
osteogenesis and primary bone tissue formation [12]. Therefore, with the proper combination of 
polycaprolactone, gelatin and HA nanoparticles, it is possible to overcome the important 
constraints of all the three materials to make this compound suitable for many biomedical 
applications.
Vitamin D3, also known as calciferol, is one of the essential vitamins for the body and a fat-
soluble vitamin, which helps bone growth and strength through the control of calcium and 
phosphorus balance. This vitamin helps the metabolism of bones by increasing the absorption of 
phosphorus and calcium from the intestines and reducing renal excretion. The shortage of this 
vitamin also causes osteoporosis in the old age [13]. Vitamin D3, from the biological aspects, 
greatly affects bone cells and contributes to the regulation of osteoblast and osteoclast activities 
that affect the bone synthesis, resorption, and regeneration processes. A prominent feature of 
vitamin D3 deficiency is the disruption of bone formation and mineralization [14]. Mason et al., 
showed that osteoblast precursors derived from human marrow (OPC1) can metabolize vitamin D 
precursors rapidly into active form of steroid (1,25OH2D3) and induce an osteogenic response. 
They showed that the use of vitamin D3 leads to increased alkaline phosphatase activity 
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associated with ECM maturation and calcium deposits. These findings provide a two-dimensional 
culture foundation for subsequent engineered tissue studies using the OPC1 cells [15]. Kato et al., 
reported a new method to purify the induced pluripotent stem (iPS)-derived osteoprogenitors 
(iPSop). They found that the use of vitamin D3 increased the expression of osteocalcin and 
reduced the expression of tissue-nonspecific alkaline phosphatase and RUNX2 in iPSop cells 
over a period of 14 days. Therefore, iPSop-day14 cells were promoted to mature osteoblasts by 
vitamin D3 treatment. In addition, they found that the vitamin D3 treatment for 14 days increased 
not only mineralization but also expression of osteocyte markers, including dentin matrix protein-
1 and fibroblast growth factor-23, in iPSop cells. Therefore, vitamin D3 is a potent promoter for 
the osteoblast-osteocyte transition [13]. Similarly, Curtis et al., showed that the vitamin D3 is an 
essential factor in the differentiation of osteoblasts from human mesenchymal stem cells [16]. 
Song et al., investigated the effect of bone morphogenetic protein-2 (BMP-2) and vitamin D3 on 
the osteogenic differentiation of ADSCs. The osteogenic differentiation was assessed by staining 
and ALP activity, and mineralization were checked by Alizarin red staining. ALP activity and 
dose-dependent mineralization was increased in the early stages (ALP activity on day 7 and 
mineralization on day 14). As a result, BMP-2 and vitamin D3 promoted the osteogenic 
differentiation of ADSCs, which can act as synergism [17].
Most of studies in this field have been conducted on animal or human bone marrow-derived 
mesenchymal stem cells (BMSCs). However, unfortunately, the use of these types of cells has 
limitations that relate to the patient's discomfort and intolerance and the pain associated with 
bone marrow sampling. As an alternative, it has been suggested to use Human adipose tissue-
derived stem cells (hADSCs) that are easily and painlessly extracted from the patient in large 
amounts. In addition, bone marrow extraction produces small amounts of cells and requires in 
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vitro culture. While adipose tissue is abundant and easy to achieve. Also, large amounts of 
hADSCs can be extracted from a small adipose tissue under local anesthesia [18]. 
In this research, the aim was to construct a PCL/Gel/nHA electrospun composite scaffold 
containing vitamin D3 to use in bone tissue engineering scaffolds. In addition, PCL/Gel/nHA/Vit 
D3 electrospun scaffold was used to culture hADSCs in vitro. The simultaneous effect of the use 
of HA nanoparticles and vitamin D3 on osteogenic differentiation of hADSCs and calcification of 
scaffolds was evaluated. 
2. MATERIALS AND METHODS 
2.1. Materials
Poly (ε-caprolactone) (PCL) (Mw = 80 kDa) was purchased by Sigma-Aldrich (St. Louis, MO). 
Gelatin (type B, from bovine skin) was provided from Merck (Darmstadt, Germany). Nano 
Hydroxyapatite (nHA) with average size 100 nm, was bought from Nick Seram Razi (Esfahan, 
Iran). Vitamin D3 was prepared from Zahravi Pharmaceutical (Tehran, Iran). Chloroform and 
acetic acid as a solvent were obtained from Merck and Sigma-Aldrich respectively. Methanol 
was purchased from Arman Sina Chemical & Pharmaceutical (Tehran, Iran). Deionized water 
was used in the experiment.
2.2. Electrospinning process
PCL (16% (w/v)) solution was solved in a mixture of chloroform/methanol (3:1 v/v). The 
solution was subjected to a magnetic stirrer for 4 hours at a speed of 600 rpm. Gelatin (8% (w/v)) 
solution was obtained using acetic acid (80 %v/v) by a magnetic stirrer at a speed of 500 rpm for 
3 hours. After preparation of polymeric solutions, PCL and gelatin in volume ratio of (PCL/Gel) 
of 70:30 were mixed together and incubated for 72 h. After 72 h of incubation, gelatin solutions 
were uniformly dispersed in PCL solution [6]. Then, 20 wt% of HA nanoparticles was added to 
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PCL/Gel solution. For dispersing nanoparticles and preventing their agglomeration, the 
compound was then ultrasonically irradiated for 10 minutes. Afterward, the desired amount of 
vitamin D3 was added to the mixture and it was again stirred with the magnetic stirrer for 10 
minutes until a solution with suitable viscosity was obtained. PCL/Gel, PCL/Gel/nHA, 
PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit D3 scaffolds were prepared using electrospinning 
method. For electrospinning process, polymer composite solutions were filled in a plastic syringe 
(2 milliliters of each solution). Then, the fibers were collected on an aluminum foil of 15 cm × 15 
cm × 1 mm. The spacing between the needle and the collector plate was adjusted to 13 cm, the 
solution injection rate to 1 ml/h and the supply voltage to 18 kV. After electrospinning, the 
scaffolds were kept in vacuum oven at 10 Pa pressure, 30 °C temperature and zero humidity for 
24 hours to dry the fibers and completely remove the solvent from them. After drying, the 
scaffolds were easily removed from the aluminum foil. 
2.3. SEM, EDX and TEM analysis
To investigate the morphology of the fibers, a scanning electron microscope (SEM) (Hitachi-
S4160, Japan) was used. For this purpose, the samples were cut in 1 cm × 1 cm and coated with 
gold for 5 minutes. Imaging was carried out at 20 kV voltage and 1 mA current. Also, Image J 
software (National Institute of Health, USA) was used for measuring the diameter size of the 
fibers and the pore size, and MATLAB software was used to calculate the porosity percentage of 
the scaffolds [19]. Also, energy-dispersive x-ray spectroscopy (EDX Pegasus X4M) and X-ray 
map techniques were used to confirm the presence and distribution of nHA particles on the 
electrospun fibers. To study the internal structure and surface roughness of the fiber, the 
transmitted electron microscope (TEM, ZEISS, Germany), was used at a voltage of 100 kV.
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2.4. Fourier Transform Infrared spectroscopy (FTIR)
Chemical analysis of PCL/Gel/nHA/Vit D3 fiber scaffold was performed by FTIR (IFS-66 V/S, 
Bruker, Ettlingen, Germany), over a wavenumber range of 400 and 4000 cm-1.
2.5. In vitro drug release
Release of vitamin D3 from electrospun mats of PCL/Gel/nHA composite contains 2% and 5% 
Vit D3 was studied. In order to evaluate the release profile of PCL/Gel/nHA/Vit D3 composite, 
10 mg of nanofiber were cut into specimens (15 mm × 15 mm) and were incubated at 37 °C in 5 
mL of deionized water containing 1% ethanol (pH = 7.4) in a thermostatic shaker [14, 20]. The 
sample of 3 mL were periodically removed at predetermined time periods for quantification 
analyses and replaced by the same volume of fresh water/ethanol. The amount of released 
vitamin D3 was measured by UV–Vis (Shimadzu Europe -UV mini-1240). All measurements 
were performed in three replicates. Additionally, standard solutions were prepared through serial 
dilution of ethanol and vitamin D3 to plot the calibration curve of the concentration of vitamin 
D3 versus absorbance at λ = 265 nm (R2 = 0.9983).
2.6. hADSCs isolation and expansion 
Adipose tissue samples were obtained from the subcutaneous of young patients aged 20-40 years 
old, who underwent liposuction surgery in the hospital according to the surgeon's discretion, after 
receiving their consent. A 20-30 ml sample of adipose tissue was taken by a surgeon in the 
operating room and under sterile conditions. Adipose tissue sample, in the culture room and 
under the biological hood and sterile conditions, was chopped using a No. 22 scalpel blade. Then, 
the resulting fragments were washed several times with an antibiotic wash solution and its outer 
medium was removed [21, 22]. After transfer of the tissue to falcon, the 0.1% collagenase 
enzyme was added to the sample and then, the sample was placed in the incubator at 37 °C. After 
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0.5 hour passed, the solution was neutralized and removed by centrifugation. To the solution at 
the bottom of the tube, which are the extracted cells, DMEM (Dulbecco's Modified Eagle 
Medium; Bio Idea, India) with low glucose concentration containing 10% FBS (fetal bovine 
serum, Bio Idea, India) and 1% penicillin/streptomycin (Bio Idea, India) was added and then the 
cells were transferred to 75 cm2 plastic tissue culture flasks. Twenty-four hours later, the cell 
culture medium was changed with a new medium. Every 2-3 days, the culture medium was 
replaced. The cells from passage 3-5 were used at this study.
2.7. Cell culture and seeding 
The scaffolds prepared prior to culture were sterilized by placing in an ultraviolet chamber for 30 
minutes. The cells were separated by Trypsin/EDTA (0.25% Trypsin in 0.04) from the flask 
surface. Then the cell suspension with specific concentration of 5×103 (cells/cm2) was added to 
each scaffold in 24-well plates. In order to evaluate the osteogenic potential of the isolated cells, 
the culture medium cells was replaced with DMEM/Ham's Nutrient Mixture F-12 (DMEM/F-12 
1: 1; Invitrogen) containing 5% FBS, 10 mM Β-glycerol phosphate (Sigma; USA), 10 nM 
Dexamethasone (Sigma; USA) and 0.2 mM ascorbic acid 2-phosphate (Sigma; USA) and 
transferred to an incubator with 5% carbon dioxide at 37±1 °C [23]. Ten types of medium-based 
groups were prepared as follows (Table 1):
[Please insert Table 1 here]
2.8. Cell morphology study
To examine the adhesion and morphology of the cells, images of the cells were obtained by invert 
and scanning electron microscopy. To this end, the cells were seed at a concentration of 5×103 
cells. After 1 and 7 days, cells were fixed with 4% glutaraldehyde solution. Subsequently, the 
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samples were dehydrated, each for 5 minutes, using 50, 70, 80, 90, 95 and 100% alcohols. 
Finally, the scaffolds were coated with gold and examined by SEM (Hitachi-S4160, Japan) [24]. 
2.9. MTT assay 
To investigate the cell toxicity and proliferation, 3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was used. The cell suspension at a concentration of 5×103 cells was cultured on 
the scaffolds. After 1, 4 and 7 days, the medium was removed from each well and the samples 
were washed with sterile PBS. Then, the medium containing 100 μl of MTT (0.5 mg/ml) was 
added to each 24-well plate. After 4 hours, the medium on the cells was removed and DMSO was 
added to dissolve generated purple formazan crystals. The concentration was then measured by a 
microplate reader (680, Bio-RAD) at a wavelength of 570 nm. A plate with higher optical density 
contains more cells [25].
2.10. Alkaline phosphatase (ALPase) activity assay 
ALP enzyme belongs to the family of hydrolyzing enzymes, which is naturally found in all body 
tissues. This enzyme in most cells is in form of cell membrane enzymes, and its high 
concentrations have been so far reported in liver, kidney, bone (osteoblast). In the bone, this 
enzyme is involved in the process of bone matrix calcification and protein production along with 
the matrix. Therefore, during production of the bone matrix by osteoblasts, the activity of this 
enzyme is highly elevated and it is used as a characteristic factor to detect the activity of 
osteoblasts in the osteogenesis process [25]. ALP assay was performed using ALP assay kit (Pars 
Azmoon, Iran) according to the manufacturer's protocol on days 7, 14 and 21. Due to the 
presence of ALP in medium, p-nitrophenyl phosphate decomposed and converted to p-
nitrophenyl. P-nitrophenyl produced a yellowish color, and this degradation reaction was 
eventually ended with the addition of 100 μl of 1N NaOH solution. In the last step, the 
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absorbance of the reaction product was evaluated using a microplate reader at the 405 nm 
wavelength [26]. 
2.11. Von Kossa staining
In order to assess the presence of inorganic matrix within the scaffolds using the invert 
microscopy, after 7, 14 and 21 days of culture of the cells on the scaffolds, they were first washed 
three times with distilled water and placed in silver nitrate solution (1%) under intense light for 
three hours. Then, silver nitrate solution was removed and the scaffolds were washed again three 
times with distilled water. By adding sodium thiosulfate solution (5%) for 5 minutes, unreacted 
silver was removed from the scaffolds. Finally, the scaffolds were washed with distilled water 
and observed by invert microscopy [27].
2.12. Alizarin red S histochemical staining
Alizarin red is used in biochemical tests to determine and measure the presence of calcium 
precipitation by osteogenic cells. Alizarin red can be used in the mineralization stages of 
extracellular matrix, during which extracellular matrix, like the actual bone, is calcined [26]. 
Alizarin red was used to detect mineralization on days 7, 14 and 21. Briefly, the scaffolds were 
washed several times with distilled water. The process of fixing the cell-scaffold structures was 
performed with a 4% paraformaldehyde for 15 minutes. Then, the scaffolds were washed again 
by distilled water. In the next stage, the cells were placed at room temperature in the presence of 
a 2% Alizarin red solution (pH= 4.1-4.3) for 45 minutes. At the end, the cells were washed twice 
with distilled water, and the stained mineral components were observed by an invert microscope. 
Quantitative measurement of amount of calcium precipitation was obtained by washing the 
scaffolds with acetone and xylene, solubilizing the red matrix precipitate in 10% cetylpyridinium 
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chloride, and reading the optical density of the solution opacity by a microplate reader at 562 nm 
[27].  
2.13. Real-time quantitative (qRT-PCR)
 Cell suspension at 2×104 cells/cm2 concentration was added to the scaffolds and the culture 
plates were incubated 37±1 °C and 5% CO2 for 21 days. The gene expression of COLL I, ALP, 
BGLAP, and RUNX2 were investigated by real-time PCR [28]. Total RNA was extracted by 
RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The RNA 
was reverse transcribed using RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific) 
with oligo dT primers. The real-time polymerase chain reaction was performed using 
BIOFACT™ 2X Real-Time PCR Master Mix kit (Biofact) and the StepOne Plus™ Real-time 
PCR Detection System (Applied Biosystems). Primer sequences are shown in Table 2. PCR 
reactions were carried out in a total volume of 20 µl. The PCR amplification conditions consisted 
of 15 min at 95 ºC followed by 40 cycles of denaturation step at 95 ºC for 15 sec and annealing 
and extension for 1 min at 60 ºC. The gene of interest was normalized against the reference gene 
glyceraldehydes-3-phosphate dehydrogenase (GAPDH). The expression level of each target gene 
was calculated by 2-ΔΔCT. These experiments were carried out in triplicate and independently 
repeated at least three times.
[Please insert Table 2 here]
2.14. Statistical analysis
One-way ANOVA followed by Tukey’s test was used for analysis of the significant difference at 





PCL/Gel, PCL/Gel/nHA, PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit D3 fibers were prepared by 
electrospinning method. The parameters of applied voltage, space between needle and collector, 
polymer solution flow rate and polymer ratio in solution were used to produce smooth and bead-
free fibers. Voltage at 18 kV, polymer solution flow rate at 1 ml/h, space between needle to 
collector of 13 cm, and mixed PCL/Gel with the ratio of 70:30 were the optimized parameters 
used in this study. Table 3 and Figure 1 show fiber properties and SEM images of composite 
scaffolds, respectively.
[Please insert Table 3 here]
As shown in Figure 1 and Table 3, all of the fibers were made in a relatively uniform size, with a 
mean diameter of 594, 631, 597 and 622 nm for PCL/Gel, PCL/Gel/nHA, PCL/Gel/Vit D3 and 
PCL/Gel/nHA/Vit D3, respectively. Adding nHA particles increased the fibers diameter size of 
PCL/Gel scaffold from 594 to 631 nm. But, by adding 2% Vit D3 (according to “3.3. Drug 
release study” section) to PCL/Gel composite scaffold, no significant change in fiber diameter 
size was observable. On the other hand, the simultaneous presence of nHA and vitamin D3 
increased the diameter size of PCL/Gel composite scaffold fiber from 594 to 622 nm. The mean 
porosity percentage and pore size of PCL/Gel/nHA/Vit D3 composite scaffold were observed to 
be about 83.11% and 8.54 μm. 
[Please insert Figure 1 here]
The EDX spectrum (Figure 2a) shows Calcium (Ca) and Phosphor (P) peaks with Ca/P = 1.68 
(major components of HA), which confirms the presence of hydroxyapatite particles in 
PCL/Gel/nHA/Vit D3 composite. The electron map image in Figure 2b shows the distribution of 
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oxygen, calcium and phosphorus elements in PCL/Gel/nHA/Vit D3 composite scaffold which 
confirms that nHA particles are distributed uniformly throughout the fiber matrix. 
[Please insert Figure 2 here]
The TEM image of PCL/Gel/nHA/Vit D3 composite scaffold is presented in Figure 3.
As can be seen, TEM has shown an almost flat surface of this fiber. Also, the results of TEM 
image show that nHA particles have a size range of 60 - 100 nm.
[Please insert Figure 3 here]
3.2. Chemical analysis of scaffolds
The results of FTIR chemical analysis to describe the functional groups in PCL/Gel/nHA/Vit D3 
composite fiber are presented in Figure 4. PCL-specific FTIR spectrum showed the peaks of 2931 
cm-1 (asymmetric CH2 stretching), 2858 cm-1 (symmetric CH2 stretching), 1722 cm-1 (C=O 
carbonyl stretching), 1292 cm-1 (C-O and C-C stretching in crystalline phases), 1239 cm-1 
(asymmetric C-O-C stretching) and peak 1161 cm-1 (symmetric C-O-C stretching) [29]. The 
FTIR spectroscopy of gelatin exhibited several characteristic bonds at 3433, 1653, 1543 and 559 
cm-1, respectively, belonging to corresponding stretching vibration of N-H (amide A), stretching 
vibration of C-O bond (amide I), due to coupling of bending of  N-H bond and stretching of C-N 
bond (amide II) and N-H [6]. Two strong bonds at 1722 and 1292 cm-1 in FTIR spectrum of 
PCL/Gel composite scaffold belong to the main PCL characteristic bonds. On the other hand, the 
characteristic bonds of gelatin amide appeared in 1653 cm-1 (amide I) and 1543 cm-1 (amide II) 
with less sharpness and were visible at 1651 and 1542 cm-1, respectively. The only difference 
between PCL and PCL/Gel bonds is the appearance of the amide group in PCL/Gel spectrum, 
which confirms the presence of gelatin in PCL fibers after combining two polymers and their 
electrospinning. The FTIR spectrum of HA nanoparticles shows five important bonds at 570 and 
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601 cm-1 (belonging to υ4 P04), 631 cm-1 (belonging to free OH ion-bonded hydrogen), 1041 cm-1 
(corresponding to υ3 PO4) and 3572 cm-1 (belonging to OH ion-bonded hydrogen stretching) [30]. 
The FTIR spectrum of PCL/Gel/nHA scaffold revealed all the characteristic bonds of PCL/Gel 
and nHA. The peaks of 570, 601 and 1041 cm-1 belonging to PO4 group of hydroxyapatite were 
seen in PCL/Gel/nHA scaffold, but not present in PCL/Gel scaffold. On the other hand, 
PCL/Gel/nHA FTIR spectrum showed the characteristic bonds of amide gelatin at 1651 (amide I) 
and 1542 cm-1 (amide II), and two peaks belonging to C=O and C-O groups of PCL at 1292 and 
1722 cm-1, respectively. According to results obtained by Urankar and Toyran, vitamin D3 FTIR 
spectroscopy had several characteristic bonds at 3300, 2940, 2850, 1650 and 1450 cm-1 [31, 32]. 
The only difference between PCL/Gel/nHA and PCL/Gel/nHA/Vit D3 bonds is the appearance of 
an asymmetric CH3 stretching at 2939 cm-1 in PCL/Gel/nHA/Vit D3 spectrum, which confirms 
the presence of vitamins D3 in PCL/Gel/nHA/Vit D3 composite scaffold after combining 
components and their electrospinning. On the other hand, C-H stretching bond at 2858 cm-1 and 
C-H bending bond at 1447 cm-1 overlap with PCL characteristic bonds, which are difficult to 
differentiate. The peaks at 1651 cm-1 and in the range of 3300 to 3500 cm-1 were assigned to 
water, which is stronger due to the hydrophobic nature of vitamin D3 in PCL/Gel/nHA. 
Therefore, according to the results, the presence of vitamin D3 was confirmed in 
PCL/Gel/nHA/Vit D3 composite scaffold.
[Please insert Figure 4 here]
3.3. Drug release study
The cumulative release profiles of vitamin D3 from electrospun PCL/Gel/nHA/Vit D3 fibers in 
water/ethanol at 37 °C within 30 days are shown in Figure 5. In PCL/Gel/nHA scaffold 
containing 2% vitamin D3, the amount of drug release over the first day was observed to be very 
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minimal and then gradually increased afterwards (Figure 5). After 30 days, the amount of 
released vitamin D3 in this scaffold was found to be 34%. The release kinetics of PCL/Gel/nHA 
scaffold containing 5% vitamin D3 can be shown in two stages, in the first phase, exhibited a 
burst effect release of about 40% at the first day. Then, in the second release phase, the remaining 
of the loaded drug was released over 30 days. Since a significant prerequisite for the successful 
designing of a drug delivery system for bone tissue engineering is the slow release of the drug 
over several weeks to sustain optimal therapeutic concentrations [20], we decided to limit our 
experiments to 2% drug loading.
[Please insert Figure 5 here]
3.4. Cell culture
Fibroblast-like morphology of cultured stem cells was observed by invert microscope (Figure 6). 
These cells were characterized in our previous study [33]. In the third passage, a uniform 
population of spindle-shaped cells with distinct nuclei was observed. To assess osteogenic 
differentiation, hADSCs in the passages 3 to 5 were used. 
[Please insert Figure 6 here]
3.5. Cell proliferation
This test was performed to evaluate the toxicity and proliferation of cells on the scaffolds. The 
quantitative analysis diagram of cell proliferation (Figure 7) shows that the proliferation of cells 
on the first day after culture did not change significantly for the scaffolds compared to the control 
sample (PCL/Gel was selected as control sample) (P>0.05). All samples were normalized to 
PCL/Gel sample. On the fourth day after culture, increased proliferation and survival of the cells 
on all the scaffolds can be clearly observed compared to the control sample. Also, the rate cell 
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viability in PCL/Gel/nHA/Vit D3 scaffold on the seventh day showed a statistically significant 
increase compared to that in the other scaffolds (P < 0.05). It should be noted that for cell culture 
testing, bone induction medium was used.
[Please insert Figure 7 here]
3.6. Cell Adhesion and Morphology
The images in Figure 8 show scanning electron microscopic images of the proliferation and 
adhesion of hADSCs cultured on the scaffolds in 1 and 7 days after culture. As seen in these 
images, after 24 hours, the cells interacted with each other in PCL/Gel/nHA, PCL/Gel/Vit D3 and 
PCL/Gel/nHA/Vit D3 scaffolds and proliferated. By comparing the microscopic images in Figure 
8, an increased cell proliferation in these three composite scaffolds compared to the pure 
PCL/Gel scaffold was observable, and these scaffolds indicated good biocompatibility as well as 
good and normal adhesion and expansion both on the days 1 and 7 after culture.  
[Please insert Figure 8 here]
3.7. Osteogenic differentiation of hADSCs on the scaffolds
ALP activity of differentiated hADSCs on the composite scaffolds on the days 7, 14 and 21 after 
culture is shown in Figure 9. According to this Figure, ALP activity was not significantly 
different between the scaffolds on the day 7 (P>0.05). On the 14th day, however, significant ALP 
activity was observed in PCL/Gel/nHA, PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit D3 scaffolds 
compared to PCL/Gel scaffold (P < 0.05). Also, the results of the 14th day showed a significant 
difference in the activity of ALP between PCL/Gel/nHA/Vit D3 scaffolds compared to 
PCL/Gel/nHA and PCL/Gel/Vit D3 scaffolds (P < 0.05). As shown in Figure 9, ALP activity of 
the scaffold groups was associated with a decrease on the 21st day.   
[Please insert Figure 9 here]
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3.8. Mineralization
To evaluate the mineral content of the matrix, calcium content of the scaffolds was evaluated by 
Alizarin red and Von Kossa staining in 7, 14 and 21 days after culture.
The results of Von Kossa staining on PCL/Gel, PCL/Gel/nHA, PCL/Gel/Vit D3 and 
PCL/Gel/nHA/Vit D3 scaffolds are shown in Figure 10. The presence of dark colored deposits 
indicates the inorganic matrix produced by stem cells cultured on PCL/Gel/nHA, PCL/Gel/Vit 
D3, and PCL/Gel/nHA/Vit D3 scaffolds. As seen from the invert microscopic images, scaffolds 
containing HA nanoparticles and vitamin D3 exhibit highest amount of mineral deposits 
compared to the other scaffolds. On the other hand, the pure PCL/Gel scaffold did not show any 
deposition on either of the days 7 and 21.
[Please insert Figure 10 here]
Figure 11 shows the images of the scaffolds after staining of Alizarin red. The staining of the 
mineral deposits in PCL/Gel scaffold was similar to each other on the day 7, 14 and 21, and no 
red deposition was observed in this scaffold. After 14 days, Alizarin red staining of the scaffolds 
confirmed the presence of mineralization in PCL/Gel/nHA, PCL/Gel/Vit D3 and 
PCL/Gel/nHA/Vit D3 scaffolds. Over time, mineral deposition in PCL/Gel/nHA, PCL/Gel/Vit 
D3, and PCL/Gel/nHA/Vit D3 scaffolds increased, which peaked on the 21st day. The staining of 
mineral deposits 21 days after culture shows that the amount of mineral deposits in 
PCL/Gel/nHA/Vit D3 scaffold matrix was more than that in PCL/Gel/nHA and PCL/Gel/Vit D3 
scaffolds in the same period. Moreover, the semi-quantitative analysis performed by extraction of 
Alizarin red spots (Figure 12) shows that the production rate of the matrix mineralized in 
PCL/Gel/nHA/Vit D3 scaffold was significantly higher on the 21st day (P < 0.05) and had a 
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statistical significant difference compared to PCL/Gel/nHA and PCL/Gel/Vit D3 scaffold (P < 
0.05). 
[Please insert Figure 11 here]
[Please insert Figure 12 here]
3.10. Expression of osteogenic markers 
Real time-PCR was used to evaluate the osteogenic genes expression of differentiated stem cells 
on the scaffolds. Four genotypes of COLL I, ALP, RUNX2, and BGLAP were evaluated in the 
study of gene expression. The results of cell gene expression analysis in the prepared scaffolds 
are shown in Figures 13 and 14. As can be seen in Figure 13, mRNA expression level in COLL I, 
BGLAP, ALP and RUNX2 increased significantly in all the scaffolds (P < 0.05) when culture 
was carried out in the bone induction medium, as compared to the cell culture medium. On the 
other hand, among the scaffold groups, there was a superior expression in PCL/Gel/nHA/Vit D3 
scaffold. COLL I, known as an early marker of osteoprogenitor cells, has upregulated in scaffold 
groups compared to control group (Figure 14). BGLAP, which appears as a late marker of 
osteoblast development with the matrix mineralization, is maximally expressed on the day 21 
(Figure 14). The level of ALP expression has been reduced on the 21st day, during the 
mineralization phase (Figure 14). Relative expression of RUNX2, a key factor in bone 
transcription, also decreased on the 21st day (Figure 14). According to Figure 14, on the 21st day 
after cell culturing, all four COLL I, BGLAP, ALP and RUNX2 genes were expressed, but 
COLL I and BGLAP had the most pronounced expression in all groups. That's while, ALP and 
RUNX2 exhibited lower expression levels than COLL I and BGLAP in the same period (Figure 
14). Regarding the semi-quantitative RT-PCR analysis, the expression levels of COLL I, 
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BGLAP, ALP and RUNX2 in the cells cultured on PCL/Gel/nHA/Vit D3 scaffold significantly 
increased, as compared with the other scaffolds (P < 0.05).
 [Please insert Figure 13 here]
[Please insert Figure 14 here]
4. DISCUSSION
Tissue engineering is the use of biological and engineering sciences to biologically regenerate or 
substitute damaged organs and lost tissues [2]. There are many methods for the production of 
three-dimensional scaffolds, and electrospinning has been widely considered recently among all 
due to its ease of use, production of very thin polymer fibers, high specific surface area and high 
modifiability [3]. Among the various polymer composites, the combination of gelatin and 
polycaprolactone has received the most attention. Polycaprolactone (a synthesized, hydrophobic, 
and flexible polymer with a low degradation rate) [4] and gelatin (a natural, hydrophilic, 
abundant polymer with a high degradation rate) blends are interesting because their components 
have completely different structures and features [6]. Research on nanostructured and 
nanoceramic (such as nHA) biocomposites suggests that these materials are a good choice for 
bone tissue engineering applications and have improved biocompatibility and mechanical 
properties. The combination of polymer nanofibers and bioactive nanoparticles can be used to 
produce composite nanofibers [9-11]. 
Vitamin D3 has a wide range of physiological functions in the body, most important of which is 
to maintain calcium and phosphorus balance. Although it has been reported in a study on mice 
[13] that treatment with vitamin D3 improves the initial stages of osteoblast differentiation in 
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vitro, other in vitro studies have shown that vitamin D3 induces expression of specific bone 
markers in stages of osteoblast differentiation [14-17]. 
Mesenchymal stem cells can be used as a suitable cellular source for reconstructive purposes in 
medicine, given their good capacity for cell proliferation and differentiation. Although BMSCs 
have been widely studied, recent hADSCs have attracted a lot of attention because they can be 
easily obtained in large quantities with the lowest cost and they have useful properties compared 
to BMSCs [18]. 
In this study, PCL/Gel composite fibers with and without nHA and Vitamin D3 were constructed 
by electrospinning method and the morphology of the scaffolds was investigated.  
The collected fibers were composed of single, homogeneous and random morphology, and no 
visible beads or small and broken fibers were found in any of the scaffolds. Also, nHA was well 
incorporated into the fibers. In consistent with previous researches at this study, smooth and 
bead-free morphology with a uniform size of fibers and optimal porosity percent with appropriate 
size was observed for PCL/Gel/nHA, PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit D3 composite 
scaffolds [7].
EDX spectral showed the presence of Ca-P in PCL/Gel/Vit D3 scaffold contains 20% HA (Figure 
2a). The spectral map scan confirmed that nHA particles were dispersed randomly within 
PCL/Gel/nHA/Vit D3 scaffold.
The TEM image showed a roughly flat surface of the fibers, which confirms the presence of nHA 
particles inside the fibers and a uniform distribution of them. But in some parts, the tendency to 
particle agglomeration is well observed, as this particle accumulation can be due to the high 
tendency of particles to reduce their surface energy.
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The FTIR spectrum of PCL/Gel composite scaffold showed all PCL and Gel characteristic bonds. 
On the other hand, the appearance of all PCL/Gel and nHA characteristic bonds in PCL/Gel/nHA 
composite fibers confirms the successful blending of HA in PCL/Gel composite scaffold. Due to 
the small proportion of the initial amount of vitamin D3 in comparison to other composite 
scaffold components, the assigned peaks for vitamin D3 were weaker than the other components 
and overlapped in some situations with PCL characteristic bonds.
The release profiles of vitamin D3 from PCL/Gel/nHA/Vit D3 scaffold have been studied in 
water/ethanol medium (pH=7.4) for 30 days at 37 ○C (Figure 5). In general, gelatin in 
PCL/Gel/nHA/Vit D3 scaffold acts as a prose-forming agent, and creates channels in the polymer 
due to its high solubility in aqueous solutions, and provides infiltration routes of water molecules 
across the polymers, and PCL hydraulic degradation also increases [34]. These channels induced 
by polymer degradation and solubility accelerate the release of drug molecules from the polymer 
matrix to the release medium [35]. On the other hand, the addition of hydroxyapatite 
nanoparticles increases the surface contact of nanoparticles and polymers, and further expands 
the polymer structure [35] and increases the infiltration of water into the polymer and enhances 
the release of vitamin D3 molecules into its release medium. PCL/Gel/nHA composite with 2% 
vitamin D3 gave about 7% release of vitamin D3 within 24 h with a smooth and regulated release 
thereafter. PCL/Gel/nHA composite with 5% vitamin D3 (Figure 5) releases vitamin D3 much 
more rapidly than the 2% sample. The initial rate of release of PCL/Gel/nHA composite with 5% 
vitamin D3 is high during the first day, most likely due to release of drug sequestered on the 
sample surfaces. Rapid release on the web containing 5% vitamins may be due to the dissolution 
and penetration of the drug. Since the drug dosage in this scaffold is higher, thus the drug 
molecules are not completely loaded in the polymer matrix and are accumulated mostly in 
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proximity and over the fiber surface [36]. Therefore, when the scaffold is in release medium, the 
drug molecules enter the medium quickly and, as a result, we will see a rapid release of vitamin 
D3 within the early hours of the web containing 5% vitamin. In lower dose of vitamin D3 (2% 
vitamin) loading, the web of nanofibers showed a slow, constant and controlled release of the 
drug, which is related to the drug infiltration into the polymer matrix, and the drug was released 
stably from the composite scaffold. 
In the next stage, cell culture was studied on PCL/Gel scaffold with and without nHA and 
vitamin D3 to obtain suitable a culture method or scaffold for proliferation of osteoblast cells.
As shown in Figure 7, all of the scaffolds showed better cell viability compared to the control 
sample (in 4 and 7 days). PCL/Gel/nHA and PCL/Gel/Vit D3 scaffolds improved the cellular 
survival compared to PCL/Gel, significantly (P < 0.05). By adding nHA improved significantly 
(P < 0.05) the cell proliferation of PCL/Gel/nHA scaffold compared to PCL/Gel within 7 days. 
This result may prove the inductive role of HA nanoparticles in the cell proliferation and 
adhesion. The positive effect of nHA on increasing the proliferation of pig and rat mesenchymal 
stem cells is also indicated by other researchers [37]. Similarly, the enhanced cell proliferation on 
scaffold containing HA fibers was also shown by Jaiswal et al [38]. On the other hand, the cell 
viability was enhanced by the addition of vitamin D3 on days 4 and 7. This may be the result of 
vitamin D3 intervention in the cellular growth and proliferation. Similarly, Fayyazbakhsh et al., 
observed a significant increase in cell proliferation by adding vitamin D3 to Hydroxides-
Hydroxyapatite/Gelatin/ vitamin D3 scaffold [39]. The results also showed that the combination 
of HA nanoparticles and vitamin D3 with PCL/Gel scaffold could significantly increase (P < 
0.05) the proliferation of hADSCs. According to the obtained results, the scaffolds not only had 
no toxic effects on the cells but also led to the well growth of the cells. 
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By comparing the scanning electron microscope images, increased cell proliferation can be 
observed in all the scaffolds 7 days after culture. However, PCL/Gel/nHA and PCL/Gel/Vit D3 
scaffolds revealed greater cell proliferation and adhesion compared to the pure PCL/Gel scaffold. 
This, on the one hand, can be due to the direct effect of vitamins D3, which led to absorption of 
more proteins of the culture environment. Furthermore, the cells have been larger on the surface 
of vitamin D3-containing scaffolds that can be a result of the interference of vitamin D3 on the 
cellular growth. It is clear that the conformation of cytoskeleton reinforced by vitamin D3 and the 
cell morphology has been transformed from nearly a rounded shape to a more spread star-like 
shape. On the other hand, this improvement in cellular growth and cell adhesion on 
PCL/Gel/nHA scaffold is considered to be a specific biological role for nHA particles. The 
presence of nHA in PCL/Gel scaffold stimulated the osteogenic properties of the cells. Hoang et 
al., stated that nHA particles are deeply involved in the initial protein adsorption, particularly in 
the selective attraction of many adhesion proteins including fibronectin, vitronectin, and bone-
specific proteins [40]. Similarly, Jaiswal et al., reported that the presence of nHA particles on the 
surface of scaffold increase the surface area as well as the surface roughness promote the 
adhesion and proliferation of cells [38]. Our results were consistent with the results of Tamjid et 
al., who stated in their study that the addition of nanoparticles to the polymer surface increased 
the effective level of particle contact with cells due to the higher tendency of nanoparticles to 
accumulate in the surface [41]. In addition, these nanoparticles have an effect on cell adhesion, 
proliferation and differentiation by creating nanotopography and increasing roughness and 
surface stiffness. On the 7th day, SEM images displayed a higher cell density in 
PCL/Gel/nHA/Vit D3 scaffold. The simultaneous presence of HA nanoparticles and vitamin D3 
increased the proliferation and adhesion of cells on PCL/Gel/nHA/Vit D3 scaffold, as compared 
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to the two other scaffolds. The results showed good biocompatibility as well as proper and 
normal adhesion, expansion and differentiation of PCL/Gel/nHA/Vit D3 scaffold on both the 
days 1 and 7 after culture. 
ALP activity is one of the main osteoblast phenotype expression markers. The results showed a 
similar trend at day 14 for ALP activity of scaffolds and all scaffolds increased ALP activity 
more than the control sample (P < 0.05). Also, PCL/Gel/Vit D3 scaffold exhibited a better ALP 
activity than PCL/Gel/nHA, hence, it can be concluded that vitamin D3 has influenced ALP 
activity stronger than HA (P < 0.05). In this study, PCL/Gel/nHA/Vit D3 scaffold exhibited the 
best ALP activity among the other scaffolds and control sample, significantly (P < 0.05). The 
high ALP activity observed on PCL/Gel/nHA/Vit D3 scaffold compared to the other scaffolds 
may be due to the synergistic effect of HA nanoparticles and vitamin D3. HA nanoparticles have 
a crystalline structure similar to the bone mineral phase and are considered as the "gold standard" 
of grafting materials and vitamin D3 has a direct effect on increased ALP activity due to 
increased production of calcium precipitation and hence, an increase in matrix mineralization 
content. Therefore, it can be said that the ALP activity is enhanced by HA and vitamin D3 due to 
the direct effect of calcium and phosphate of HA, and indirect effect of vitamin D3 on calcium 
and phosphate regulation via the cell membrane ion channels. These observations were in 
agreement with other studies, in which ALP activity increased with adding HA [42]. Similarly, 
Song et al., studied the effect of vitamin D3 on osteogenic differentiation of ADSCs [17]. They 
observed that with the addition of vitamin D3, the ALP activity increases in the early stages (on 
day 7). As a result, vitamin D3 promoted the osteogenic differentiation of ADSCs [17]. The 
increased ALP activity on the 7th to 14th days can be due to entering into the stage of ECM 
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development and maturity, which is observable with increasing ALP activity. As shown in Figure 
9, ALP activity of the scaffolds on the 21st day was associated with a decrease. Reduction of 
ALP activity during 14 to 21 days after culture for all the scaffolds can be attributed to the 
complete maturity of ECM and the qualification and preparation of the scaffolds for entering into 
the mineralization stage. This pattern has been acceptable by the prior results [43], therefore, it 
can be said that the scaffolds enhanced the osteoblastic phenotype expression as the specific 
function of natural bone. There is also a general consensus between the findings of the present 
study and the findings obtained by Nigiam et al., based on which there is an increased ALP 
activity in PLGA/HA scaffold [44]. In light of these results, it is observed that hADSCs are well 
reproduced on this composite scaffold and organized to achieve a PCL/Gel/nHA/Vit D3 mineral 
matrix in order to be used for bone tissue engineering in vitro.
In the present work, we observed an increase of mineral deposition by Von Kossa and Alizarin 
red staining on the scaffolds. The staining of mineral deposits 21 days after culture shows that the 
amount of mineral deposits in PCL/Gel/nHA/Vit D3 scaffold matrix was more than that in 
PCL/Gel/nHA and PCL/Gel/Vit D3 scaffolds within the same period. Moreover, the semi-
quantitative analysis performed by extraction of Alizarin red spots shows that PCL/Gel/Vit D3 
scaffold exhibited the mineral deposition more than PCL/Gel/nHA. According to the results, the 
vitamin D3 containing scaffolds facilitate the calcium mineralization due to the effect of vitamin 
D3 on calcium regulation. Vitamin D3 has a key role in the bone mineralization due to ionic 
regulation and ALP activity [45]. As a major result of biological evaluation, it seems that vitamin 
D3 acted as a signaling factor to enhance the osteoblastic activity and bone regeneration. On the 
other hand, nHA particles can be a template for secondary HA formation, and therefore a 
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template for the in vitro biomineralization process. Based on the results PCL/Gel/nHA/Vit D3 
scaffold due to the simultaneous presence of HA nanoparticles (with a crystalline structure 
similar to the bone mineral phase) and vitamin D3 exhibited highest amount of mineral deposits 
compared to the other scaffolds.
Real-time PCR method was conducted to determine the expression of osteogenic markers such as 
COLL I, ALP, RUNX2 and BGLAP of differentiated cells on the scaffolds. According to the our 
results, PCL/Gel/nHA and PCL/Gel/Vit D3 scaffolds provided a suitable medium for maintaining 
the differentiation of osteoblasts; however,  PCL/Gel/Vit D3 scaffold showed a higher expression 
level of bone genes as compared to PCL/Gel/nHA. On the other hand, PCL/Gel/nHA scaffold 
containing vitamin D3 has revealed far higher expression levels for specific osteoblast genes. 
Earlier in the study of Kato et al., it was shown that vitamin D3 could be a potent accelerator of 
osteodifferentiation, particularly from late- to early-phase osteocytes. They showed that treatment 
with vitamin D3 increased all osteoblast markers in iPSop-day4 cells and MSCop-day4 cells [13]. 
As previously mentioned, it seems that vitamin D3 acted as a signaling factor to enhance the 
osteoblastic activity and bone regeneration. On the other hand, Chen et al., found that HA 
nanoparticles have a significant effect on osteogenic differentiation of mesenchymal stem cells 
since it stimulates the expression of bone genes [46]. Another study also reported that HA with a 
specific molecular weight and dose increases osteogenic and osteoconductivity properties [47]. 
Therefore, it can be argued that the presence of nHA and vitamin D3 in a scaffold leads to a 
much better growth and differentiation of osteoblasts and better bone tissue production since they 
simulate a medium like an extracellular matrix for cells. The present study indicates that vitamin 
D3 and HA affect the process of osteogenic differentiation of mesenchymal stem cells. From the 
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comparison of osteogenic related genes among groups can be found that COLL I and BGLAP 
exhibited higher levels of expression and ALP and RUNX2 lower expression levels in all groups. 
On the other hand, mRNA level of COLL I, BGLAP, ALP and RUNX2 in all scaffolds 
significantly increased when culture was carried out in the bone induction medium, as compared 
to the cell culture medium. Based on these results, it was shown that the scaffolds and bone 
induction medium have a more suitable environment for the differentiation of adipose tissue stem 
cells than the cell culture medium. Therefore, it can be concluded that many parameters can 
direct the stem cells derived from adipose tissue towards the bone. For example, the proper 
scaffold and the use of a bone differentiation medium are factors playing an important role in 
bone formation and have a great impact on cellular differentiation. The findings of the present 
study were consistent with Kulterer [48]. They showed that the bone formation at laboratory 
conditions is carried out in 3 stages:
1. ECM bio-proliferation and synthesis 
2. ECM development and maturation through increasing ALP activity
3. ECM mineralization where HA is organized and deposited.
In the first stage after cell culture, the cells are actively proliferated (for the first 10 to 12 days 
after culture) and several genes associated with the formation of ECM, including COLL I, are 
seriously expressed. Subsequently, the proliferation rate gradually decreases and ECM maturity 
begins. Immediately after this decrement in proliferation, ALP activity is greatly increased. This 
occurs during the days 12 and 18. At this time, ECM is matured and qualified to be mineralized. 
In the third stage of bone growth, ALP expression is reduced and other genes associated with 
bone mineralization, such as BGLAP, are expressed at the maximum level.
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According to the findings of this study and Kulterer et al., it can be concluded that increasing the 
expression of BGLAP gene on day 21 may be related to the final stage of bone formation, i.e. 
ECM mineralization along with the calcium precipitation [48].
On the other hand, the reduced expression of ALP gene during the same period can be attributed 
to the complete maturity of ECM and the qualification and preparation of scaffolds for entering 
the mineralization stage. COLL I, known as an early marker of osteoprogenitor cells, increased 
throughout this period. RUNX2 gene is expressed during the bone formation period; however, the 
differentiation is accompanied with different expressions at different times. The information 
driven from real time-PCR profile revealed the expected expression of the bone phenotype. 
5. CONCLUSIONS
In this study, the electrospun nanocomposite scaffold with novel combination of 
PCL/Gel/nHA/Vit D3 was presented to use in bone tissue engineering. A smooth and bead-free 
morphology with uniform fiber diameter size and optimal porosity with appropriate size was 
observed for all scaffolds. In FTIR spectrum of PCL/Gel/nHA/Vit D3 composite fiber, appeared 
all the characteristic peaks of PCL/Gel/nHA and Vit D3, which confirmed the successful 
integration of nHA and Vit D3 into PCL/Gel composite scaffolds. Release of vitamin D3 from 
electrospun fibers of PCL/Gel/nHA/Vit D3 composite was studied and it was found that 
electrospun PCL/Gel/nHA containing 2% vitamin D3 fiber gave relatively smooth release of drug 
over about 30 days. In addition, the culture hADSCs on novel combination of 
PCL/Gel/nHA/Vitamin D3 was performed and analyzed. The results of cell toxicity and 
proliferation showed that electrospun composite scaffolds were biocompatible and had no 
negative effect on adipose tissue stem cells in vitro. The results of hADSCs cultured on the 
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scaffolds revealed the normal morphology and proper adhesion of all scaffolds. The simultaneous 
effect of the use of HA nanoparticles and vitamin D3 on osteogenic differentiation of hADSCs 
and calcification of scaffolds was studied. As the main indicators of osteoconductivity, the 
calcium deposition and ALP activity have promoted significantly because of the direct effect of 
HA and indirect intervention of vitamin D3 in the calcium and phosphate regulation. In 
particular, the cells cultured on PCL/Gel/nHA/Vit D3 scaffold had a significant increase in terms 
of ALP activity (on the 14th day) and scaffold mineralization (on the 21st day) compared to the 
two other scaffolds, indicating that vitamin D3 and HA increase the osteogenic differentiation of 
hADSCs. It was found that the treatment with nHA and vitamin D3 for 21 days not only 
increases mineralization but also upregulates the expression of osteoblast markers, including 
ALP, COLL I, BGLAP and RUNX2, in hADSCs cells. Additionally, when the adipose tissue 
stem cells were induced with osteogenic medium, the expression of specific bone genes 
significantly increased. These findings suggest that hADSCs can be used for osteogenic 
differentiation to reduce the cost imposed by a clinical program. Using HA nanoparticles and 
vitamin D3, a method could be developed to induce beneficial and cost-effective bone formation 
caused by hADSCs in bone tissue engineering.
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Figures captions
Figure 1: SEM images of fibers at 2500X magnification
Figure 2: (a) The EDX spectrum of PCL/Gel/nHA/Vit D3 composite and (b) EDX element 
mapping analysis of  PCL/Gel/nHA/Vit D3 composite scaffold, (scale bar = 500 μm)
Figure 3: TEM image of PCL/Gel/nHA/Vit D3 fiber
Figure 4: FTIR spectra of PCL, Gel, PCL/Gel, nHA, PCL/Gel/nHA and PCL/Gel/nHA/Vit D3 
samples
Figure 5: Cumulative vitamin D3 release profiles from PCL/Gel/nHA with 2 and 5% Vit D3 
Figure 6: The image provided by an invert microscope from stem cells cultured on the 
polystyrene culture flask floor at 40X magnification
Figure 7: Cell proliferation as indicated by MTT assay of hADSCs seeded on scaffolds in bone 
induction medium (+) after 1, 4 and 7 days, (*): P< 0.05
Figure 8: Morphology of hADSCs on scaffolds in bone induction medium (+) after 1 and 7 days 
of cell seeding at 125X and 500X magnification
Figure 9: ALP analysis on scaffolds in bone induction medium (+) after 7, 14 and 21 days, (*): 
P< 0.05
Figure 10: Von Kossa staining of differentiated hADSCs on scaffolds in bone induction medium 
(+) after 7 and 21 days of cell seeding at 40X magnification
Figure 11: Alizarin red staining of differentiated hADSCs on scaffolds in bone induction medium 
(+) after 7, 14 and 21 days at 40X magnification
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Figure 12: Quantitative measurements of mineral deposition in differentiated hADSCs by 
Alizarin red staining on scaffolds in bone induction medium (+) after 7, 14 and 21 days, (*): P< 
0.05
Figure 13: Comparison of the results of the gene expression analysis of hADSCs cultured on the 
scaffolds in both the bone induction and cell culture medium after 21 days, (*): P< 0.05
Figure 14: Comparison of the results of COLL I, BGLAP, ALP and RUNX2 among groups in 















Table 1: The sample code used in cell culture 
Number Sample Code Sample Material
1 -control cells free scaffold
2 -PG PCL/Gel scaffold with cells
3 -PGH PCL/Gel/nHA scaffold with cells
4 -PGV PCL/Gel/Vit D3 scaffold with cells
5 -PGHV PCL/Gel/nHA/Vit D3 scaffold with cells
6 +control
Negative control complemented with osteogenic factors consisting of 
β-glycerol phosphate, dexamethasone, ascorbic acid-2-phosphate 
(representing the +control)
7 +PG PCL/Gel scaffold with cells
8 +PGH PCL/Gel/nHA scaffold with cells
9 +PGV PCL/Gel/Vit D3 scaffold with cells
10 +PGHV PCL/Gel/nHA/Vit D3 scaffold with cells
(-) Cell culture medium, (+) Bone induction medium




 (5' → 3') Scale (OD)
Number of
Nucleotides
GAPDH-F TTGAGGTCAATGAAGGGGTC 4 18
GAPDH-R GAAGGTGAAGGTCGGAGTCA 4 18
COLL I-F CCGTGACCTCAAGATGTG 4 18
COLL I-R CCATACTCGAACTGGAATC 4 19
RUNX2-F CGGAATGCCTCTGCTGTTATG  4 21
RUNX2-R TGTCTGTGCCTTCTGGGTTC  4 20
ALP-F TTGACCTCCTCGGAAGACA 4 19
ALP-R GTAGTTGTTGTGAGCATAGTCC 4 22
BGLAP-F TTGGACACAAAGGCTGCAC  4 19
BGLAP-R CTCACACTCCTCGCCCTATT    4 20
Table 3: The fibers properties of PCL/Gel, PCL/Gel/nHA, PCL/Gel/Vit D3 and PCL/Gel/nHA/Vit 
D3 electrospun
Sample Diameter (nm) Pore Size (µm) Porosity (%)
PCL/Gel 594 ± 83.15 8.21 82.19
PCL/Gel/nHA 631 ± 90.40 8.73 83.52
PCL/Gel/Vit D3 558 ± 66.21 8.15 82.02
PCL/Gel/nHA/Vit D3 622 ± 82.82 8.54 83.11
